Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New Study Further Supports Safety of Promensil(R) as a Natural, Effective Way to Manage Mild-to-Moderate Menopausal Symptoms
May 1st, 2008
Natrol, Inc., the exclusive U.S. licensee for Promensil(R) and a premier marketer and manufacturer of nationally branded nutritional products, announces the results of a large, three-year study -- published in the journal Menopause International -- reinforcing the safety of this red clover isoflavone supplement for managing hot flashes and other menopausal symptoms.(1)(a) Furthermore, this new study shows that Promensil, containing a standardized supplement of red clover isoflavones, has a neutral effect on breast density in women with a family history of breast cancer. This is in contrast to studies showing that some conventional...
Source: Women's Health Weekly (2008-05-01)
|
